Senthilnath Lakshmana Chetty, PhD

Title(s)Postdoctoral Scholar, Neurological Surgery
SchoolSchool of Medicine
Address1450 Third Street, #402
San Francisco CA 94158
Phone415-476-1637
ORCID ORCID Icon0000-0002-3760-2772 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Texas at San AntonioM.S12/2011Biotechnology
    University of Colorado Anschutz Medical CampusPh.D12/2018Cell biology, Stem cells, and Development

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma. Sci Rep. 2024 03 16; 14(1):6362. Nejo T, Wang L, Leung KK, Wang A, Lakshmanachetty S, Gallus M, Kwok DW, Hong C, Chen LH, Carrera DA, Zhang MY, Stevers NO, Maldonado GC, Yamamichi A, Watchmaker PB, Naik A, Shai A, Phillips JJ, Chang SM, Wiita AP, Wells JA, Costello JF, Diaz AA, Okada H. PMID: 38493204; PMCID: PMC10944514.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Correction: Gallus et al. Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma. Cancers 2023, 15, 3726. Cancers (Basel). 2023 Dec 26; 16(1). Gallus M, Kwok D, Lakshmanachetty S, Yamamichi A, Okada H. PMID: 38201665; PMCID: PMC10778241.
      View in: PubMed   Mentions:
    3. Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma. bioRxiv. 2023 Nov 02. Nejo T, Wang L, Leung KK, Wang A, Lakshmanachetty S, Gallus M, Kwok DW, Hong C, Chen LH, Carrera DA, Zhang MY, Stevers NO, Maldonado GC, Yamamichi A, Watchmaker P, Naik A, Shai A, Phillips JJ, Chang SM, Wiita AP, Wells JA, Costello JF, Diaz AA, Okada H. PMID: 37961484; PMCID: PMC10634890.
      View in: PubMed   Mentions:
    4. Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens. bioRxiv. 2023 Oct 20. Kwok DW, Stevers NO, Nejo T, Chen LH, Etxeberria I, Jung J, Okada K, Cove MC, Lakshmanachetty S, Gallus M, Barpanda A, Hong C, Chan GKL, Wu SH, Ramos E, Yamamichi A, Liu J, Watchmaker P, Ogino H, Saijo A, Du A, Grishanina N, Woo J, Diaz A, Chang SM, Phillips JJ, Wiita AP, Klebanoff CA, Costello JF, Okada H. PMID: 37904942; PMCID: PMC10614978.
      View in: PubMed   Mentions:
    5. Glioma-neuronal circuit remodeling induces regional immunosuppression. bioRxiv. 2023 Aug 06. Nejo T, Krishna S, Jimenez C, Yamamichi A, Young JS, Lakshmanachetty S, Chen T, Phyu SSS, Ogino H, Watchmaker P, Diebold D, Choudhury A, Daniel AGS, Raleigh DR, Hervey-Jumper SL, Okada H. PMID: 37577659; PMCID: PMC10418167.
      View in: PubMed   Mentions:
    6. Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma. Cancers (Basel). 2023 Jul 22; 15(14). Gallus M, Kwok D, Lakshmanachetty S, Yamamichi A, Okada H. PMID: 37509387; PMCID: PMC10378701.
      View in: PubMed   Mentions: 1  
    7. Mapping the tumor-infiltrating immune cells during glioblastoma progression. Nat Immunol. 2022 06; 23(6):826-828. Lakshmanachetty S, Mitra SS. PMID: 35624212.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    8. Venetoclax Cooperates with Ionizing Radiation to Attenuate Diffuse Midline Glioma Tumor Growth. Clin Cancer Res. 2022 06 01; 28(11):2409-2424. Madhavan K, Balakrishnan I, Lakshmanachetty S, Pierce A, Sanford B, Fosmire S, Elajaili HB, Walker F, Wang D, Nozik ES, Mitra SS, Dahl NA, Vibhakar R, Venkataraman S. PMID: 35344040.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    9. Targeting the TP53/MDM2 axis enhances radiation sensitivity in atypical teratoid rhabdoid tumors. Int J Oncol. 2022 Mar; 60(3). Alimova I, Wang D, Danis E, Pierce A, Donson A, Serkova N, Madhavan K, Lakshmanachetty S, Balakrishnan I, Foreman NK, Mitra S, Venkataraman S, Vibhakar R. PMID: 35179215; PMCID: PMC8878716.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    10. New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs. Cells. 2021 04 14; 10(4). Lakshmanachetty S, Cruz-Cruz J, Hoffmeyer E, Cole AP, Mitra SS. PMID: 33919732; PMCID: PMC8070707.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    11. Microglia in the Brain Tumor Microenvironment. Adv Exp Med Biol. 2020; 1273:197-208. Cole AP, Hoffmeyer E, Chetty SL, Cruz-Cruz J, Hamrick F, Youssef O, Cheshier S, Mitra SS. PMID: 33119883.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    12. Loss of TP63 Promotes the Metastasis of Head and Neck Squamous Cell Carcinoma by Activating MAPK and STAT3 Signaling. Mol Cancer Res. 2019 06; 17(6):1279-1293. Lakshmanachetty S, Balaiya V, High WA, Koster MI. PMID: 30910837; PMCID: PMC6548645.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    13. TRP63/TP63 loss accelerates skin tumorigenesis through activation of Wnt/β-catenin signaling. J Dermatol Sci. 2018 Sep; 91(3):325-328. Lakshmanachetty S, Balaiya V, Johnson LK, Koster MI. PMID: 29885760; PMCID: PMC6151152.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    14. A Human Stem Cell-Based System to Study the Role of TP63 Mutations in Ectodermal Dysplasias. J Invest Dermatol. 2018 07; 138(7):1662-1665. Dinella JD, Chen J, Webb S, Siegfried E, Bree AF, Lakshmanachetty S, Balaiya V, Koster MI, Koch PJ. PMID: 29481901; PMCID: PMC6019602.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    15. Emerging roles for collagen XV and XVIII in cancer progression. Exp Dermatol. 2016 05; 25(5):346-7. Lakshmanachetty S, Koster MI. PMID: 26835883.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice. Vaccine. 2013 Nov 19; 31(48):5722-8. Li W, Murthy AK, Lanka GK, Chetty SL, Yu JJ, Chambers JP, Zhong G, Forsthuber TG, Guentzel MN, Arulanandam BP. PMID: 24096029; PMCID: PMC3843363.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    17. Francisella DnaK inhibits tissue-nonspecific alkaline phosphatase. J Biol Chem. 2012 Oct 26; 287(44):37185-94. Arulanandam BP, Chetty SL, Yu JJ, Leonard S, Klose K, Seshu J, Cap A, Valdes JJ, Chambers JP. PMID: 22923614; PMCID: PMC3481318.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    Senthilnath's Networks
    Concepts (105)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (17)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.